Study of Postoperative Delirium in Elderly People After Orthopedic Surgery
Launched by ZHONGNAN HOSPITAL · Jun 26, 2016
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
Postoperative delirium is one of the most common postoperative complications in elderly patients.It has been shown that postoperative delirium has independent adverse effects on short and long-term mortality and morbidity, including poor functional recovery, postoperative cognitive dysfunction, deterioration in quality of life, and increased costs. However, at the present time, postoperative delirium is a clinical phenomenon, and its neuropathogenesis remains unknown. This gap in knowledge has become a barrier that limits further studies, including the development of potential interventions...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 65 years old or older
- • 2. candidates for spinal anesthesia
- • 3. Non language communication barriers
- Exclusion Criteria:
- • 1. past medical history of neurological and psychiatric diseases including AD, other forms of dementia, stroke, or psychosis;
- • 2. severe visual or hearing impairment;
- • 3. unwillingness to comply with the protocol or procedures.
About Zhongnan Hospital
Zhongnan Hospital, affiliated with Wuhan University, is a leading medical institution in China renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on multidisciplinary collaboration, the hospital employs state-of-the-art facilities and a team of highly skilled professionals to conduct rigorous clinical studies aimed at improving patient outcomes. Zhongnan Hospital prioritizes ethical standards and patient safety, ensuring adherence to regulatory requirements while fostering a culture of scientific excellence. As a prominent sponsor of clinical trials, the hospital plays a pivotal role in contributing to the global medical community and enhancing the understanding of various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Mian Peng, MD
Study Director
Zhongnan Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials